Literature DB >> 658099

Weekly administration of cis-diamminedichloroplatinum (II) without hydration or osmotic diuresis.

V L Randolph, R E Wittes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 658099     DOI： 10.1016/0014-2964(78)90004-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  [The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)].

Authors:  T G Wendt; R Hartenstein; U Büll; K Schlechtweg; E A Moser
Journal:  Klin Wochenschr       Date:  1983-06-01

2.  Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.

Authors:  A S Planting; M E van der Burg; M de Boer-Dennert; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

3.  Criteria for the selection of second-generation platinum compounds.

Authors:  R Shepherd; H Kusnierczyk; M Jones; K R Harrap
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.